Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03235479 · ClinicalTrials.gov registry record · Phase 3
Safety and Efficacy Study in Adult Subjects With Acute Migraines
A Phase 3 study of Migraine With or Without Aura, sponsored by Pfizer.
- Completed
- Registry status
- Phase 3
- Development phase
- 1,485
- Enrollment target
- 20
- Study locations
NCT03235479 is a Phase 3 study of Migraine With or Without Aura that has completed, run by Pfizer. The registered enrollment target is 1,485 participants. The trial reports 20 study locations across 9 states.
The verdict
NCT03235479, a Phase 3 study of Migraine With or Without Aura, has completed, sponsored by Pfizer.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 1,485 participants
- Enrollment target
- 20
- Study locations
Study Summary
The purpose of this study is to compare the efficacy of BHV-3000 (rimegepant) versus placebo in subjects with Acute Migraines
Conditions Studied
Interventions
- DRUG Placebo
- DRUG Rimegepant
Study Locations (20)
Florida
- Qps Mra, Llc - Hollywood
- Multi-Specialty Research Associates, Inc - Lake City
- Qps Mra, Llc - Miami
- Advanced Pharma CR, LLC - Miami
- Compass Research, LLC - Orlando
- Ormond Medical Arts Pharmaceutical Research - Ormond Beach
California
- Pharmacology Research Institute - Encino
- Optimus Medical Group - San Francisco
- California Medical Clinic for Headache - Santa Monica
- Diablo Clinical Research, Inc - Walnut Creek
Arizona
- Neurological Physicians of Arizona/Radiant Research Inc - Gilbert
- Clinical Research Consortium Arizona - Tempe
- Radiant Research, Inc. - Tucson
Massachusetts
- Boston Clinical Trials, Inc - Boston
- Milford Emergency Associates, Inc. - Marlborough
Alabama
- Central Research Associates, Inc - Birmingham
Arkansas
- Woodland International Research Group, LLC - Little Rock
Georgia
- Meridian Clinical Research - Savannah
Louisiana
- New Orleans Center for Clinical Research - New Orleans
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,485 participants |
| Start Date | 2017-07-18 |
| Est. Completion | 2018-01-26 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03235479
The ClinicalTrials.gov registry entry for NCT03235479 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 1,485 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Pfizer, which has 1,845 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Migraine With or Without Aura appearing as the primary indexed condition, and to 2 interventions - of which Placebo is the first listed.
NCT03235479 reports 20 study locations spanning 9 distinct geographic areas - top geographies include Florida, California, Arizona.
Frequently Asked Questions
What is clinical trial NCT03235479 about?
NCT03235479 is a clinical study titled "Safety and Efficacy Study in Adult Subjects With Acute Migraines". The purpose of this study is to compare the efficacy of BHV-3000 (rimegepant) versus placebo in subjects with Acute Migraines
What is the current status of trial NCT03235479?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 1,485 participants. The study started on 2017-07-18. Estimated completion is 2018-01-26.
What conditions does trial NCT03235479 study?
This clinical trial studies the following conditions: Migraine With or Without Aura.
What interventions are being tested in trial NCT03235479?
The interventions under investigation include: Placebo (DRUG), Rimegepant (DRUG).
Who is sponsoring clinical trial NCT03235479?
This trial is sponsored by Pfizer, which has 1,845 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03235479 being conducted?
This trial has 20 study locations across Alabama, Arizona, Arkansas, California, Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Migraine With or Without Aura
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.